{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:10:45Z","timestamp":1760238645192,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi-Aventis Poland"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>In Poland, drotaverine is the most frequently purchased antispasmodic, yet there is a paucity of real-world data on its use. We evaluated the profiles of patients who used drotaverine, and we investigated prescription patterns among general practitioners (GPs). In this cross-sectional, questionnaire-based study, we asked patients who purchased drotaverine about their reasons for using it, its perceived efficacy, satisfaction with treatment, and physician consultation. We also asked GPs about the status of drotaverine in their practice. Among 650 recruited patients, 74% used drotaverine for pain, 67% for cramps, and 19% for abdominal discomfort. Approximately 83% of patients purchased drotaverine without a physician\u2019s advice. Patients who used it after a physician\u2019s advice were more frequently female, older, and less educated. For all symptoms, mean severity scores decreased by ~5 points (0\u201310 scale) after the first dose. Ninety-eight percent of patients were satisfied with drotaverine. Among 210 GPs, the percentages prescribing drotaverine were: 42% for irritable bowel syndrome, 89% for cholelithiasis, 60% as supportive therapy for urinary infections, 89% for nephrolithiasis, and 75% for menstruation pain. The GPs perceived drotaverine as more useful, effective, and tolerable than other drugs for abdominal pain or cramps. Drotaverine significantly reduced the severity of all symptoms for which it was taken, and it was perceived as effective and tolerable.<\/jats:p>","DOI":"10.3390\/jcm11113156","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T12:48:31Z","timestamp":1654087711000},"page":"3156","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-Medication with Drotaverine among Patients with Common Abdominal Symptoms and Treatment Efficacy from the Perspectives of Patients and General Practitioners\u2014An Observational, Retrospective, Cross-Sectional Study Using Real-World Data"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9306-5038","authenticated-orcid":false,"given":"Piotr","family":"Eder","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Dietetics and Internal Medicine, Heliodor Swiecicki University Hospital, Poznan University of Medical Sciences, Ul. Przybyszewskiego 49, 60-355 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8446-8238","authenticated-orcid":false,"given":"Piotr","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Gdansk, Al. Hallera 107, 80-416 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-2760","authenticated-orcid":false,"given":"Agnieszka","family":"Mastalerz-Migas","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Medical University of Wroclaw, Ul. Syrokomli 1, 51-141 Wroclaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Skrzydlo-Radomanska","sequence":"additional","affiliation":[{"name":"Department and Clinic of Gastroenterology with the Endoscopy Laboratory of the Medical University of Lublin, Aleje Raclawickie 1, 20-059 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Cichy","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Calisia University-Kalisz, Ul. Nowy Swiat 4, 62-800 Kalisz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Proga","sequence":"additional","affiliation":[{"name":"PEX PharmaSequence Sp. z o.o., Ul. Klobucka 23, 02-699 Warszawa, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF01719573","article-title":"Epidemiology of abdominal symptoms in a random population: Prevalence, incidence, and natural history","volume":"10","author":"Kay","year":"1994","journal-title":"Eur. J. Epidemiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5114\/pg.2012.27218","article-title":"Prevalence of abdominal symptoms in the Polish population","volume":"1","author":"Pacholec","year":"2012","journal-title":"Gastroenterol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e00328","DOI":"10.1016\/j.heliyon.2017.e00328","article-title":"Abdominal symptoms in general practice: Frequency, cancer suspicions raised, and actions taken by GPs in six European countries. Cohort study with prospective registration of cancer","volume":"3","author":"Holtedahl","year":"2017","journal-title":"Heliyon"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s13312-015-0730-y","article-title":"Efficacy and safety of drotaverine hydrochloride in children with recurrent abdominal pain: A randomized placebo controlled trial","volume":"52","author":"Narang","year":"2015","journal-title":"Indian Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1111\/jgh.14370","article-title":"Efficacy and safety of fixed-dose combination of drotaverine hydrochloride (80 mg) and paracetamol (500 mg) in amelioration of abdominal pain in acute infectious gastroenteritis: A randomized controlled trial","volume":"33","author":"Narang","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejogrb.2010.05.007","article-title":"Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: A double-blind, double-dummy, randomized comparative study with aceclofenac","volume":"152","author":"Pareek","year":"2010","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/1319-3767.145331","article-title":"Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: A randomized double-blind placebo-controlled study","volume":"20","author":"Rai","year":"2014","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1046\/j.1464-410X.2003.04262.x","article-title":"The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones","volume":"92","author":"Romics","year":"2003","journal-title":"BJU Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/cts.13129","article-title":"How can real-world evidence aid decision making during the life cycle of nonprescription medicines?","volume":"15","author":"Csoke","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJPR\/2016\/30333","article-title":"Self-medication; An Emerging Trend","volume":"14","author":"Mehmood","year":"2016","journal-title":"Br. J. Pharm. Res."},{"key":"ref_11","unstructured":"Eurostat (2021, October 15). Self-Reported Use of Non-Prescribed Medicines by Sex, Age and Educational Attainment Level. Available online: https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/hlth_ehis_md2e\/default\/table?lang=en."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4103\/0253-7613.190728","article-title":"Drug-related problems associated with self-medication and medication guided by prescription: A pharmacy-based survey","volume":"48","author":"Panda","year":"2016","journal-title":"Indian J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1197\/jamia.M2449","article-title":"Consumer Health Information Seeking as Hypothesis Testing","volume":"15","author":"Keselman","year":"2008","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chatila, R., Merhi, M., Hariri, E., Sabbah, N., and Deeb, M.E. (2017). Irritable bowel syndrome: Prevalence, risk factors in an adult Lebanese population. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0698-2"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Orlando, V., Mucherino, S., Guarino, I., Guerriero, F., Trama, U., and Menditto, E. (2020). Gender Differences in Medication Use: A Drug Utilization Study Based on Real World Data. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17113926"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6358624","DOI":"10.1155\/2018\/6358624","article-title":"\u201cBrave Men\u201d and \u201cEmotional Women\u201d: A Theory-Guided Literature Review on Gender Bias in Health Care and Gendered Norms towards Patients with Chronic Pain","volume":"2018","author":"Samulowitz","year":"2018","journal-title":"Pain Res. Manag."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000510950","article-title":"Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: A Pilot Study","volume":"39","year":"2021","journal-title":"Dig. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/02813430410006503","article-title":"Abdominal complaints in general practice Diagnoses and characteristics of patients","volume":"22","author":"Vandvik","year":"2004","journal-title":"Scand. J. Prim. Health Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/sjg.SJG_266_20","article-title":"Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study","volume":"27","author":"Rai","year":"2021","journal-title":"Saudi J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e9235","DOI":"10.1097\/MD.0000000000009235","article-title":"Randomized controlled study of efficacy and safety of drotaverine hydrochloride in patients with irritable bowel syndrome","volume":"96","author":"Xue","year":"2017","journal-title":"Medicine"},{"key":"ref_21","first-page":"32","article-title":"Preference trends for antispasmodics among Indian healthcare professionals: Results of a cross sectional survey","volume":"68","author":"Gabhane","year":"2015","journal-title":"Indian Pract."},{"key":"ref_22","first-page":"933","article-title":"Comparative efficacy and tolerability of drotaverine 80 mg and ibuprofen 400 mg in patients with primary dysmenorrhoea\u2014Protocol DOROTA","volume":"78","author":"Debski","year":"2007","journal-title":"Ginekol. Pol."},{"key":"ref_23","first-page":"CD001751","article-title":"Nonsteroidal anti-inflammatory drugs for dysmenorrhoea","volume":"7","author":"Marjoribanks","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MEG.0000000000002288","article-title":"Healthcare practitioners\u2019 diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: A cross-sectional survey","volume":"34","author":"Hartleb","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5603\/PJNNS.a2021.0045","article-title":"Migraine diagnosis and treatment in Poland: Survey of primary care practitioners","volume":"55","author":"Domitrz","year":"2021","journal-title":"Neurol. Neurochir. Pol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/11\/3156\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:23:29Z","timestamp":1760138609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/11\/3156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["jcm11113156"],"URL":"https:\/\/doi.org\/10.3390\/jcm11113156","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}